60 Degrees Pharmaceuticals Sets Date for Babesiosis Study Data Release, KOL Webinar
60 Degrees Pharmaceuticals, Inc. announced it will disclose interim data from its hospitalized babesiosis study and hold a Key Opinion Leader webinar.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.